Global Microrna Reverse Transcription Market Analysis

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Global Microrna Reverse Transcription Market Analysis

  • Healthcare
  • Published Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 8
  • No of Figures: 42

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 YEARS CONSIDERED FOR THE STUDY

2.3 CURRENCY AND PRICING

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 MULTIVARIATE MODELLING

2.6 PRODUCT TYPE LIFELINE CURVE

2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.8 DBMR MARKET POSITION GRID

2.9 MARKET END USER COVERAGE GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 INDUSTRIAL INSIGHTS:

5 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: REGULATIONS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING PREVALENCE OF CANCER AND NEUROLOGICAL DISORDER

6.1.2 INCREASE IN GERIATRIC POPULATION

6.1.3 INCREASE IN EARLY DIAGNOSIS RATE

6.1.4 INCREASE IN ADVANCED TECHNOLOGY

6.2 RESTRAINTS

6.2.1 HIGH COST OF PRODUCTS

6.2.2 NON-AVAILABILITY OF RELEVANT AND APPROPRIATE KITS

6.2.3 PRESENCE OF ALTERNATIVE TECHNIQUES

6.3 OPPORTUNITIES

6.3.1 RISE IN GOVERNMENT FUNDING FOR HEALTHCARE

6.3.2 RISE IN HEALTHCARE EXPENDITURE

6.4 CHALLENGES

6.4.1 LACK OF SKILLED WORKFORCE

6.4.2 OPERATIONAL BARRIERS FACED IN CONDUCTING DIAGNOSTIC TESTS

7 IMPACT OF COVID-19 PANDEMIC ON THE MARKET

7.1 IMPACT ON PRICE

7.2 IMPACT ON DEMAND

7.3 IMPACT ON SUPPLY CHAIN

7.4 STRATEGIC DECISIONS FOR MANUFACTURERS

7.5 CONCLUSION

8 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY PRODUCT TYPE

8.1 OVERVIEW

8.2 KITS AND REAGENTS

8.3 INSTRUMENTS

8.4 CONSUMABLES

9 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY SERVICES

9.1 OVERVIEW

9.2 SAMPLE COLLECTION

9.2.1 PLASMA

9.2.2 SERUM

9.2.3 WHOLE BLOOD

9.2.4 OTHERS

9.3 OTHER SERVICES

10 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY METHOD

10.1 BY METHOD TYPES

10.1.1 OVERVIEW

10.1.2 REVERSE TRANSCRIPTION

10.1.3 QPCR

10.2 ON THE BASIS OF RT-QPCR

10.2.1 OVERVIEW

10.2.2 STEM LOOP RT-QPCR

10.2.3 POLYADENYLATION BASED RT-QPCR

10.2.4 MI-QPCR

10.2.5 OTHERS

10.3 ON THE BASIS OF KITS, REAGENTS AND CONSUMABLES

10.3.1 OVERVIEW

10.3.2 QUANTITATIVE PCR

10.3.3 RNA-SEQUENCING

10.3.4 MICROARRAYS

10.3.5 IN-SITU HYBRIDIZATION

10.3.6 OTHERS

11 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY APPLICATION

11.1 OVERVIEW

11.2 CANCER

11.3 CARDIOVASCULAR DISEASE

11.4 NEUROLOGICAL DISEASE

11.5 KIDNEY DISEASE

11.6 OTHERS

12 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY END USER

12.1 OVERVIEW

12.2 ACADEMIC AND RESEARCH INSTITUTES

12.3 BIOPHARMACEUTICAL COMPANIES

12.4 CONTRACT RESEARCH ORGANIZATIONS

12.5 DIAGNOSTIC CENTERS

13 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: GLOBAL

14 COMPANY PROFILE

14.1 THERMO FISHER SCIENTIFIC INC

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 PRODUCT PORTFOLIO

14.1.4 RECENT DEVELOPMENTS

14.2 ILLUMINA, INC

14.2.1 COMPANY SNAPSHOT

14.2.2 RECENT FINANCIALS

14.2.3 PRODUCT PORTFOLIO

14.2.4 RECENT DEVELOPMENTS

14.3 AGILENT TECHNOLOGIES, INC.

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 PRODUCT PORTFOLIO

14.3.4 RECENT DEVELOPMENTS

14.4 BIO-RAD LABORATORIES, INC.

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 PRODUCT PORTFOLIO

14.4.4 RECENT DEVELOPMENTS

14.5 MERCK KGAA, DARMSTADT, GERMANY

14.5.1 COMPANY SNAPSHOT

14.5.2 RECENT FINANCIALS

14.5.3 PRODUCT PORTFOLIO

14.5.4 RECENT DEVELOPMENTS

14.6 QIAGEN

14.6.1 COMPANY SNAPSHOT

14.6.2 REVENUE ANALYSIS

14.6.3 PRODUCT PORTFOLIO

14.6.4 RECENT DEVELOPMENTS

14.7 ABCAM PLC

14.7.1 COMPANY SNAPSHOT

14.7.2 REVENUE ANALYSIS

14.7.3 PRODUCT PORTFOLIO

14.7.4 RECENT DEVELOPMENTS

14.8 APPLIED BIOLOGICAL MATERIALS INC. (ABM)

14.8.1 COMPANY SNAPSHOT

14.8.2 PRODUCT PORTFOLIO

14.8.3 RECENT DEVELOPMENT

14.9 BIOGENEX

14.9.1 COMPANY SNAPSHOT

14.9.2 PRODUCT PORTFOLIO

14.9.3 RECENT DEVELOPMENTS

14.1 GENECOPOEIA, INC.

14.10.1 COMPANY SNAPSHOT

14.10.2 PRODUCT PORTFOLIO

14.10.3 RECENT DEVELOPMENT

14.11 GENOSENSOR CORPORATION

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT DEVELOPMENT

14.12 HTG MOLECULAR DIAGNOSTICS, INC.

14.12.1 COMPANY SNAPSHOT

14.12.2 RECENT FINANCIALS

14.12.3 PRODUCT PORTFOLIO

14.12.4 RECENT DEVELOPMENT

14.13 HORIZON DISCOVERY LTD.

14.13.1 COMPANY SNAPSHOT

14.13.2 PRODUCT PORTFOLIO

14.13.3 RECENT DEVELOPMENTS

14.14 MILTENYI BIOTEC

14.14.1 COMPANY SNAPSHOT

14.14.2 PRODUCT PORTFOLIO

14.14.3 RECENT DEVELOPMENT

14.15 MIRXES PTE LTD

14.15.1 COMPANY SNAPSHOT

14.15.2 PRODUCT PORTFOLIO

14.15.3 RECENT DEVELOPMENT

14.16 NANJING VAZYME BIOTECH CO.,LTD.

14.16.1 COMPANY SNAPSHOT

14.16.2 PRODUCT PORTFOLIO

14.16.3 RECENT DEVELOPMENTS

14.17 NANOSTRING

14.17.1 COMPANY SNAPSHOT

14.17.2 REVENUE ANALYSIS

14.17.3 PRODUCT PORTFOLIO

14.17.4 RECENT DEVELOPMENT

14.18 NEW ENGLAND BIOLABS

14.18.1 COMPANY SNAPSHOT

14.18.2 PRODUCT PORTFOLIO

14.18.3 RECENT DEVELOPMENTS

14.19 NORGEN BIOTEK CORP.

14.19.1 COMPANY SNAPSHOT

14.19.2 PRODUCT PORTFOLIO

14.19.3 RECENT DEVELOPMENTS

14.2 ORIGENE TECHNOLOGIES, INC.

14.20.1 COMPANY SNAPSHOT

14.20.2 PRODUCT PORTFOLIO

14.20.3 RECENT DEVELOPMENT

14.21 QUANTABIO

14.21.1 COMPANY SNAPSHOT

14.21.2 PRODUCT PORTFOLIO

14.21.3 RECENT DEVELOPMENTS

14.22 SEQMATIC LLC.

14.22.1 COMPANY SNAPSHOT

14.22.2 PRODUCT PORTFOLIO

14.22.3 RECENT DEVELOPMENT

14.23 SYSTEM BIOSCIENCES, LLC.

14.23.1 COMPANY SNAPSHOT

14.23.2 PRODUCT PORTFOLIO

14.23.3 RECENT DEVELOPMENT

14.24 TAKARA BIO INC.

14.24.1 COMPANY SNAPSHOT

14.24.2 RECENT FINANCIALS

14.24.3 PRODUCT PORTFOLIO

14.24.4 RECENT DEVELOPMENTS

15 QUESTIONNAIRE

16 RELATED REPORTS

List of Table

TABLE 1 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 2 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 3 GLOBAL SAMPLE COLLECTION IN MICRORNA REVERSE TRANSCRIPTION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 4 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 5 GLOBAL RT-QPCR IN MICRORNA REVERSE TRANSCRIPTION MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 6 GLOBAL KITS, REAGENTS AND CONSUMABLES IN MICRORNA REVERSE TRANSCRIPTION MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 7 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 8 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY END USER, 2020-2029 (USD MILLION)

List of Figure

FIGURE 1 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: SEGMENTATION

FIGURE 2 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: DATA TRIANGULATION

FIGURE 3 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: GLOBAL VS REGIONAL ANALYSIS

FIGURE 5 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: DBMR MARKET POSITION GRID

FIGURE 8 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: MARKET END USER COVERAGE GRID

FIGURE 9 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: SEGMENTATION

FIGURE 11 INCREASING PREVALENCE OF CANCER AND NEUROLOGICAL DISORDER IS EXPECTED TO DRIVE THE GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET IN 2022 & 2029

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET

FIGURE 14 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY PRODUCT TYPE, 2021

FIGURE 15 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)

FIGURE 16 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY PRODUCT TYPE, CAGR (2022-2029)

FIGURE 17 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 18 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY SERVICES, 2021

FIGURE 19 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY SERVICES, 2022-2029 (USD MILLION)

FIGURE 20 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY SERVICES, CAGR (2022-2029)

FIGURE 21 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY SERVICES, LIFELINE CURVE

FIGURE 22 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY METHOD, 2021

FIGURE 23 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY METHOD, 2022-2029 (USD MILLION)

FIGURE 24 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY METHOD, CAGR (2022-2029)

FIGURE 25 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY METHOD, LIFELINE CURVE

FIGURE 26 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY METHOD, 2021

FIGURE 27 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY METHOD, 2022-2029 (USD MILLION)

FIGURE 28 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY METHOD, CAGR (2022-2029)

FIGURE 29 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY METHOD, LIFELINE CURVE

FIGURE 30 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY METHOD, 2021

FIGURE 31 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY METHOD, 2022-2029 (USD MILLION)

FIGURE 32 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY METHOD, CAGR (2022-2029)

FIGURE 33 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY METHOD, LIFELINE CURVE

FIGURE 34 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY APPLICATION, 2021

FIGURE 35 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

FIGURE 36 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 37 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 38 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY END USER, 2021

FIGURE 39 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY END USER, 2022-2029 (USD MILLION)

FIGURE 40 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY END USER, CAGR (2022-2029)

FIGURE 41 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: BY END USER, LIFELINE CURVE

FIGURE 42 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET: COMPANY SHARE 2021 (%)

Frequently Asked Questions

The microRNA Reverse Transcription Market will grow at a CAGR of 16.4% during the forecast period of 2022 to 2029.
The significant factors flourishing the growth of the microRNA Reverse Transcription Market are Increasing Prevalence of Cancer and Neurological Disorder and Increasing Increase in the Early Diagnosis Rate.
The major players operating in the microRNA Reverse Transcription Market are Thermofisher Scientific Inc., Agilent, Illumina, Inc., Merck KgaA, QIAGEN, Bio-Rad Laboratories, Inc., MiRXES Pte Ltd., Abcam plc, Takara Bio Inc., Quantabio, Horizon Discovery Ltd., NanoString., BioGenex, SeqMatic LLC, GenoSensor, LLC, OriGene Technologies, Inc., System Biosciences, LLC. , HTG Molecular Diagnostics, Inc., GeneCopoeia, Inc., New England Biolabs, Miltenyi Biotec and/or its affiliates, Applied Biological Materials Inc. (abm), Norgen Biotek Corp., Nanjing Vazyme Biotech Co.,Ltd.
On the basis of application, the microRNA Reverse Transcription Market is segmented into Cancer, Kidney Disease, Neurological Disease, Cardiovascular Disease, Others.